A phase II trial of reduced doses of a highly active antiretroviral treatment in patients with advanced stages of the type 1human immunodeficiency virus infection

Category Systematic review
JournalMed. interna Méx
Year 1999
This article has no abstract
Epistemonikos ID: 7af28231af56d8b2fbdfb34e8e9c3a9cf90dfb58
First added on: Nov 27, 2024